Evidence map›Paper›PMID 37901244›Full record

ArticleFrontiers in immunology2023

Chinese medicine, Qijudihuang pill, mediates cholesterol metabolism and regulates gut microbiota in high-fat diet-fed mice, implications for age-related macular degeneration.

Yanqun Cao, Khalid S Ibrahim, Xing Li, Aileen Wong, Yi Wu, Xu-Dong Yu, Xinzhi Zhou, Zhoujin Tan, Zhiming He, John A Craft and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Yanqun CaoPu Ai Medical School, Shaoyang University, Shaoyang, Hunan, China.
Khalid S IbrahimDepartment of Biological and Biomedical Sciences , Glasgow Caledonian University, Glasgow, United Kingdom.
Xing LiPu Ai Medical School, Shaoyang University, Shaoyang, Hunan, China.
Aileen WongDepartment of Biological and Biomedical Sciences , Glasgow Caledonian University, Glasgow, United Kingdom.
Yi WuSchool of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Xu-Dong YuPu Ai Medical School, Shaoyang University, Shaoyang, Hunan, China.
Xinzhi ZhouDepartment of Biological and Biomedical Sciences , Glasgow Caledonian University, Glasgow, United Kingdom.
Zhoujin TanSchool of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Zhiming HePu Ai Medical School, Shaoyang University, Shaoyang, Hunan, China.
John A CraftDepartment of Biological and Biomedical Sciences , Glasgow Caledonian University, Glasgow, United Kingdom.
Xinhua ShuPu Ai Medical School, Shaoyang University, Shaoyang, Hunan, China.
Glasgow Caledonian University · GBShaoyang University · CNHunan University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Traditional Chinese Medicines have been used for thousands of years but without any sound empirical basis. One such preparation is the Qijudihuang pill (QP), a mixture of eight herbs, that has been used in China for the treatment of various conditions including age-related macular degeneration (AMD), the most common cause of blindness in the aged population. In order to explain the mechanism behind the effect of QP, we used an AMD model of high-fat diet (HFD) fed mice to investigate cholesterol homeostasis, oxidative stress, inflammation and gut microbiota. Methods: Mice were randomly divided into three groups, one group was fed with control diet (CD), the other two groups were fed with high-fat-diet (HFD). One HFD group was treated with QP, both CD and the other HFD groups were treated with vehicles. Tissue samples were collected after the treatment. Cholesterol levels in retina, retinal pigment epithelium (RPE), liver and serum were determined using a commercial kit. The expression of enzymes involved in cholesterol metabolism, inflammation and oxidative stress was measured with qRT-PCR. Gut microbiota was analyzed using 16S rRNA sequencing. Results: In the majority of the lipid determinations, analytes were elevated by HFD but this was reversed by QP. Cholesterol metabolism including the enzymes of bile acid (BA) formation was suppressed by HFD but again this was reversed by QP. BAs play a major role in signaling between host and microbiome and this is disrupted by HFD resulting in major changes in the composition of colonic bacterial communities. Associated with these changes are predictions of the metabolic pathway complexity and abundance of individual pathways. These concerned substrate breakdowns, energy production and the biosynthesis of pro-inflammatory factors but were changed back to control characteristics by QP. Conclusion: We propose that the ability of QP to reverse these HFD-induced effects is related to mechanisms acting to lower cholesterol level, oxidative stress and inflammation, and to modulate gut microbiota.

Indexed as

Gastrointestinal MicrobiomeMacular DegenerationAnimalsCholesterolDiet, High-FatInflammationMedicine, Chinese TraditionalMiceRNA, Ribosomal, 16SCholesterolRNA, Ribosomal, 16Sage-related macular degenerationcholesterolgut microbiotainflammationoxidative stressQijudihuang pilltraditional Chinese medicine

Identifiers

PMID37901244
PMCPMC10602650
OpenAlexW4387570448

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.